NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,009 filers reported holding NOVARTIS A G in Q1 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $345,086 | +4.6% | 3,388 | +3.6% | 0.01% | 0.0% |
Q2 2023 | $330,061 | +7.3% | 3,271 | -2.1% | 0.01% | 0.0% |
Q1 2023 | $307,507 | +101387.5% | 3,342 | 0.0% | 0.01% | 0.0% |
Q4 2022 | $303 | -99.9% | 3,342 | -3.1% | 0.01% | +12.5% |
Q3 2022 | $262,000 | -10.3% | 3,448 | -0.2% | 0.01% | 0.0% |
Q2 2022 | $292,000 | -7.9% | 3,455 | -4.5% | 0.01% | 0.0% |
Q1 2022 | $317,000 | -2.5% | 3,616 | -2.9% | 0.01% | 0.0% |
Q4 2021 | $325,000 | -38.2% | 3,723 | -42.1% | 0.01% | -42.9% |
Q3 2021 | $526,000 | +58.4% | 6,429 | +76.5% | 0.01% | +55.6% |
Q2 2021 | $332,000 | +7.4% | 3,643 | +0.8% | 0.01% | 0.0% |
Q1 2021 | $309,000 | -10.2% | 3,613 | -0.6% | 0.01% | -18.2% |
Q4 2020 | $344,000 | +15.1% | 3,636 | +5.8% | 0.01% | -8.3% |
Q3 2020 | $299,000 | -0.3% | 3,438 | 0.0% | 0.01% | -7.7% |
Q2 2020 | $300,000 | +11.1% | 3,438 | +5.1% | 0.01% | +8.3% |
Q1 2020 | $270,000 | -20.1% | 3,270 | -8.4% | 0.01% | -7.7% |
Q4 2019 | $338,000 | +8.7% | 3,570 | 0.0% | 0.01% | -7.1% |
Q3 2019 | $311,000 | -5.8% | 3,570 | -1.1% | 0.01% | -6.7% |
Q2 2019 | $330,000 | -27.3% | 3,611 | -23.6% | 0.02% | -28.6% |
Q1 2019 | $454,000 | +12.7% | 4,729 | +0.7% | 0.02% | +10.5% |
Q4 2018 | $403,000 | -0.5% | 4,695 | 0.0% | 0.02% | +18.8% |
Q3 2018 | $405,000 | +14.1% | 4,695 | 0.0% | 0.02% | +6.7% |
Q2 2018 | $355,000 | -29.6% | 4,695 | -24.7% | 0.02% | -34.8% |
Q1 2018 | $504,000 | +13.8% | 6,232 | +18.3% | 0.02% | -4.2% |
Q4 2017 | $443,000 | +21.0% | 5,269 | +23.4% | 0.02% | +14.3% |
Q3 2017 | $366,000 | +5.8% | 4,269 | +3.0% | 0.02% | -4.5% |
Q2 2017 | $346,000 | +12.3% | 4,144 | 0.0% | 0.02% | +4.8% |
Q1 2017 | $308,000 | +2.0% | 4,144 | 0.0% | 0.02% | -4.5% |
Q4 2016 | $302,000 | +39.2% | 4,144 | +51.0% | 0.02% | 0.0% |
Q3 2016 | $217,000 | -4.0% | 2,744 | 0.0% | 0.02% | -15.4% |
Q2 2016 | $226,000 | -52.8% | 2,744 | -48.9% | 0.03% | -16.1% |
Q4 2015 | $479,000 | +90.1% | 5,369 | +95.7% | 0.03% | -3.1% |
Q3 2015 | $252,000 | +5.9% | 2,744 | +13.2% | 0.03% | +14.3% |
Q2 2015 | $238,000 | -0.4% | 2,425 | – | 0.03% | -3.4% |
Q1 2015 | $239,000 | -1.6% | 0 | -100.0% | 0.03% | -3.3% |
Q4 2014 | $243,000 | -24.5% | 2,625 | -37.5% | 0.03% | -45.5% |
Q3 2013 | $322,000 | +8.4% | 4,200 | 0.0% | 0.06% | +7.8% |
Q2 2013 | $297,000 | – | 4,200 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |